University of Gothenburg
Pink and orange graphic, Photo by Landon Arnold on Unsplash
Photo: Landon Arnold (Unsplash)

About us

About the Wallenberg Centre for Molecular and Translational Medicine.

Wallenberg Centre of Molecular and Translational Medicine is a research Center at the University of Gothenburg. The Center is built in cooperation with Region Västra Götaland and AstraZeneca. The close interaction between the partners have been of importance to ensure that researchers from basic research diciplines meet with clinically oriented researchers for a truly translational focus.

The investment covers SEK 620 million over a ten year period. The Wallenberg Foundation has previously decided to contribute 270 million, Västra Götaland 150 million, Astra Zeneca will contribute with time and resources comprising 40 million for the first four years (with a possible extension thereafter), while the University of Gothenburg enters 160 million.

Steering Committee

  • Eva Wiberg, Vice-Chancellor (chair)
  • Göran Landberg Deputy Vice-Chancellor for research
  • Göran Hilmersson, Dean, Faculty of Science
  • Lena Carlsson, Assistant Dean for research, Sahlgrenska Academy
  • Per Albertsson, Acting FoU-director, County Region West
  • Pernille Laerkegaard Hansen, Head of Department, Chronic Kidney Disease, CVRM iMED, AstraZeneca Göteborg
  • Jan Holmgren, representing Knut and Alice Wallenberg Foundation (co-opted member)
  • Christina Jern, Director WCMTM (co-opted member)
  • Julia Grönros, Research Coordinator WCMTM (secretary)
  • Margit Mahlapuu, Co-Director WCMTM (co-opted member)

Scientific Advisory Board (SAB)

  • Professor David Carling, Professor of Biochemistry, Institute of Clinical Science, Faculty of Medicine, Imperial College London, UK
  • Professor Kirsten Ohm Kyvik, MD, Head of Department for Clinical Research, University of Southern Denmark, Denmark
  • Professor Leif Andersson, MD,Professor in Pathology,  Helsinki University, Finland


Christina Jern


Christina Jern is the director of the Wallenberg Centre for Molecular and Translational Medicine. She is also professor of neurology at the Sahlgrenska Academy and chief physician at the Sahlgrenska University Hospital. Her research is mainly focused on stroke, its origin and the conditions of life after a stroke.

Margit Mahlapuu


Margit Mahlapuu is the new co-director of the Wallenberg Centre for Molecular and Translational Medicine. She is also professor of molecular genetics at the Faculty of Science. She runs a research group focusing on type 2 diabetes and has experience from C-level management in drug discovery and development.

Julia Grönros

Research Advisor and Coordinator

Phone: 0046 (0)766186113

Julia is the research coordinator of Wallenberg Centre for Molecular and Translational Medicine. Together with the director Christina Jern, she manages all Centre activities and new recruitments, and work to build translational environments and strong links between the University of Gothenburg, Sahlgrenska University Hospital and Astra Zeneca for the up to 20 research groups and associated researchers that will be part of the Centre. Julia holds a PhD in physiology from University of Gothenburg and has worked several years at AstraZeneca as a researcher in cardiovascular and kidney disease.

Joel Jakobsson

Research Advisor

Louise Nilsson 

Project Manager

Project Manager for WCMTM based at Biobank Väst at Sahlgrenska University Hospital. Louise is the key person for support to the WCMTM-researchers in both regulatory and operational areas of biobanking and clinical studies. Louise’s scientific background consists of studies in biomedical chemistry, MSc, continued by graduate studies in medicine, PhD University of Gothenburg, and a postdoc period affiliated to Lund University. Then she spent a number of years as information scientist and clinical development associate manager at AstraZeneca.

Kristina Lindblom


The National Effort

The Wallenberg Centre for Molecular Medicine the University of Gothenburg along with the universities in Lund, Umeå and Linköping, and also SciLifeLab, forms a part of a national initiative to help Sweden regain its world leading position within medical research.


The Wallenberg Centers for Molecular Medicine represents a ten-year and more than 800 million SEK investment from KAW encompassing young scientists from the fields of molecular and translational medicine. This recruitment of fellows and associated clinical fellows, specialists in clinical medicine, builds on the KAW national effort to reposition Sweden as a world-leading life science nation. The four WCMMs are located at University of Gothenburg, Linköping University, Lund University and Umeå University. Each center is co-funded by the universities, municipalities, regions, industry organizations and other local funding.